Replimune (REPL) Total Non-Current Liabilities (2018 - 2025)

Replimune's (REPL) quarterly Total Non-Current Liabilities came in at $122.4 million in Q4 2025, up 1.98% year-on-year from $120.0 million in Q4 2024, and down 2.25% quarter-over-quarter from $125.2 million in Q3 2025.

Replimune (REPL) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends

Replimune has disclosed Total Non-Current Liabilities across 6 years of filings, most recently posting $122.4 million for Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $122.4 million, up 1.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $122.4 million (up 1.98% YoY), and the FY2025 annual result was $134.5 million, up 19.67% from the prior year.
  • Total Non-Current Liabilities came in at $122.4 million for Q4 2025 at Replimune, down from $125.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $134.5 million in Q1 2025 to a low of $50.0 million in Q1 2022.
  • The 4-year median for Total Non-Current Liabilities is $112.4 million (2024), against an average of $108.3 million.
  • Across the five-year window, Total Non-Current Liabilities surged 81.79% in 2023 and gained 1.98% in 2025, its largest moves.
  • Replimune's Total Non-Current Liabilities stood at $50.0 million in 2022, then soared by 121.36% to $110.6 million in 2023, then grew by 8.49% to $120.0 million in 2024, then rose by 1.98% to $122.4 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $122.4 million (Q4 2025), $125.2 million (Q3 2025), and $131.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 42,980.09
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 11.03 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 644,700.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.71 Bn 91.71 Bn - 64.76 Mn
10 Replimune 780.01 Mn 510.88 Mn - 122.36 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 122.36 Mn
Sep 30, 2025 125.17 Mn
Jun 30, 2025 131.85 Mn
Mar 31, 2025 134.54 Mn
Dec 31, 2024 119.99 Mn
Sep 30, 2024 115.96 Mn
Jun 30, 2024 107.73 Mn
Mar 31, 2024 112.43 Mn
Dec 31, 2023 110.60 Mn
Sep 30, 2023 96.75 Mn
Jun 30, 2023 89.28 Mn
Mar 31, 2023 90.83 Mn
Mar 31, 2022 49.96 Mn
Mar 31, 2019 16.47 Mn
Dec 31, 2018 8.95 Mn
Sep 30, 2018 3.78 Mn
Jun 30, 2018 4.54 Mn
Mar 31, 2018 5.22 Mn